How to use the speech recognition tool?
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With Retinitis Pigmentosa Due to Mutations in Exon 13 of the USH2A Gene (Stellar).
Status of the trial: Active, Recruiting
Orphan Drug Recognition: No
- Opening Date: 2019-03-27
- Closing Date: 2022-06-01
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: